 | Up a level |
Lee, I. Russel and Tong, Steven Y. C. and Davis, Joshua S. and Paterson, David L. and Syed Omar, Sharifah Faridah and Peck, Kwong Ran and Chung, Doo Ryeon and Cooke, Graham S. and Libau, Eshele Anak and Rahman, Siti-Nabilah B. A. and Gandhi, Mihir P. and Shi, Luming and Zheng, Shuwei and Chaung, Jenna and Tan, Seow Yen and Kalimuddin, Shirin and Archuleta, Sophia and Lye, David C. (2022) Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): Study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial. Trials, 23 (1). ISSN 1745-6215, DOI https://doi.org/10.1186/s13063-022-06495-3.
Roberts, Leah W. and Harris, Patrick N.A. and Forde, Brian M. and Ben Zakour, Nouri L. and Catchpoole, Elizabeth and Stanton-Cook, Mitchell and Phan, Minh-Duy and Sidjabat, Hanna E. and Bergh, Haakon and Heney, Claire and Gawthorne, Jayde A. and Lipman, Jeffrey and Allworth, Anthony and Chan, Kok Gan and Chong, Teik Min and Yin, Wai Fong and Schembri, Mark A. and Paterson, David L. and Beatson, Scott A. (2020) Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei. Nature Communications, 11 (1). p. 466. ISSN 2041-1723, DOI https://doi.org/10.1038/s41467-019-14139-5.
